Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 10/gram
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Factory Price 99% Raw Material Triamterene Powder CAS 396-01-0 Triamterene |
Appearance | white powder |
CAS | 396-01-0 |
Assay | 99% |
Keywords | Triamterene;Triamterene Powder;Triamterene CAS 396-01-0 |
Shelf Life | 24 months when properly stored |
Storage | Keep in a cool, dry, dark location |
Diuretic effect: The diuretic effect of amphenopterine is relatively mild, unlike strong diuretics such as furosemide, which can cause a large amount of fluid and electrolyte loss quickly. It is mainly by inhibiting the reabsorption of sodium ions by the distal convoluted tubules and collecting tubules, which gradually increases the urine volume. At normal doses, it can effectively reduce fluid retention in the body and improve edema symptoms.
Potassium retention effect: Its most significant feature is the effect of potassium retention. During the diuretic process, it can reduce the excretion of potassium ions and help maintain blood potassium within the normal range. This is very important for patients who use diuretics for a long time, because hypokalemia may cause a series of complications such as arrhythmia and muscle weakness. Amphenopterine reduces the risk of hypokalemia due to diuresis, allowing patients to maintain electrolyte stability while undergoing diuretic treatment.
Cardiogenic edema: In patients with heart failure, due to the weakened pumping function of the heart, venous return is blocked, which leads to fluid retention in the tissue space and edema. Amphenopterine can reduce fluid retention in the body and relieve edema symptoms through diuretic action. It can be used in combination with other heart failure medications (such as cardiotonic drugs, blood vessel dilators) to help patients expel excess water and reduce the preload on the heart.
Hepatogenic edema: For edema caused by liver diseases such as cirrhosis, amphenopteridine also has certain application value. In cirrhosis, the function of the liver to synthesize proteins is reduced, resulting in the decrease of plasma colloid osmotic pressure, and at the same time, due to the portal vein pressure and other factors, the fluid seeps from the blood vessel into the tissue space to form edema. Amphenopterine reduces the amount of fluid in the body by diuresis, alleviating edema, and its potassium-conserving properties help prevent electrolyte disturbances due to diuresis, which is particularly important in patients with impaired liver function.
Nephrogenic edema: In some kidney diseases (such as nephrotic syndrome), edema also occurs due to impaired glomerular filtration or abnormal tubular reabsorption function. Amphenopterine can regulate the function of renal tubules, promote the discharge of water and sodium, and reduce edema. However, the dosage needs to be adjusted according to the patient's kidney function, because the metabolism and excretion of the drug may be affected when the kidney function is severely impaired.
Product Name | CAS No. | Product Name | CAS No. |
Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |
Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
RU 58841 | 154992-24-2 | cb-03-01 | 19608-29-8 |
Biotin | 58-85-5 | Biotinoyl tripeptide-1 | 299157-54-3 |
Finasteride | 98319-26-7 | Dutasteride | 164656-23-9 |